Position in PCVX
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$3,593,871
+$280,327 QoQ
Shares Held
61,846
-13.9% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANQUE PICTET & CIE SA holds $180,153,862 across 15 Biotechnology names. PCVX ranks #4 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
2,748,754 | $139,636,703 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,550 | $12,748,717 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,893 | $7,643,727 | |
| 4 | PCVX |
Vaxcyte, Inc.
This page
|
61,846 | $3,593,871 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
49,367 | $2,379,489 | |
| 6 | IMVT |
Immunovant, Inc.
|
88,660 | $2,202,314 | |
| 7 | AVIR |
Atea Pharmaceuticals, Inc.
|
345,077 | $1,856,514 | |
| 8 | BNTX |
BioNTech SE
|
19,677 | $1,748,891 |
All Filings in PCVX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,593,871 | 61,846 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $3,313,544 | 71,815 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,696,601 | 74,864 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,710,423 | 83,372 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,189,211 | 57,977 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,855,525 | 59,315 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $7,401,496 | 64,772 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $4,460,904 | 59,077 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $4,159,190 | 60,887 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||